Cantargia AB Revenue and Competitors

Lund,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Cantargia AB's estimated annual revenue is currently $5.9M per year.(i)
  • Cantargia AB's estimated revenue per employee is $155,000

Employee Data

  • Cantargia AB has 38 Employees.(i)
  • Cantargia AB grew their employee count by -12% last year.

Cantargia AB's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Clinical DevelopmentReveal Email/Phone
3
Director Clinical DevelopmentReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
IP and Communications ManagerReveal Email/Phone
6
Project Manager PreclinicalReveal Email/Phone
7
Senior Data Manager/BioinformaticianReveal Email/Phone
8
Preclinical ScientistReveal Email/Phone
9
Executive AssistantReveal Email/Phone
10
Financial ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Cantargia AB?

Cantargia develops antibody based therapy against the target IL1RAP. The lead candidate CAN04 is for treatment of solid tumors and hematoligacal cancers, entering phase I/IIa clinical development.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$5.9M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cantargia AB News

2022-04-17 - Kallelse till årsstämma i Cantargia AB (publ) - Cantargia AB

Aktieägarna i Cantargia AB (publ) kallas till årsstämma måndagen den 23 maj 2022 kl. 16.00 på Ideon Gateway, Scheelevägen 27, i Lund.

2022-04-17 - Notice of annual general meeting in Cantargia AB (publ)

STOCKHOLM, April 22, 2022 /PRNewswire/ -- The shareholders of Cantargia AB (publ) are invited to the annual general meeting on Monday,...

2022-03-22 - Cantargia strengthens executive management in preparation for late ...

STOCKHOLM, March 10, 2022 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced the strengthening of its medical...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.9M3841%N/A
#2
$6.2M405%N/A
#3
$5M438%N/A
#4
N/A43169%N/A
#5
$8.4M4316%N/A